Clinical Trials on Attentional Control Switching in South Africa
Total 1535 results
-
Novartis PharmaceuticalsCompletedAttention-Deficit/Hyperactivity Disorder (ADHD)United States
-
ShireCompletedAttention Deficit Hyperactivity Disorder (ADHD)United States
-
ShireCompletedAttention Deficit Hyperactivity Disorder (ADHD)United States
-
Cingulate TherapeuticsPremier Research Group plcActive, not recruitingADHD | Attention Deficit Hyperactivity Disorder | ADHD - Combined Type | Attention Deficit Hyperactivity Disorder Combined | Attention Deficit Hyper Activity | Attention-deficit HyperactivityUnited States
-
Eli Lilly and CompanyCompletedAttention Deficit Hyperactivity DisorderUnited States, Australia, Belgium, Canada, France, Germany, Israel, Italy, Netherlands, Norway, Puerto Rico, South Africa, Sweden, United Kingdom
-
Alcobra Ltd.TerminatedAttention Deficit Hyperactivity Disorder (ADHD)United States, Israel
-
SanofiCompletedAlzheimer's DiseaseSweden, Bulgaria, France, Netherlands, South Africa
-
Ironshore Pharmaceuticals and Development, IncCompletedAttention Deficit Hyperactivity DisorderUnited States
-
SunovionCompleted
-
Eli Lilly and CompanyCompletedAttention Deficit Hyperactivity DisorderUnited States, Puerto Rico
-
Alcobra Ltd.CompletedADHD | Attention-Deficit/Hyperactivity Disorder, Predominantly Inattentive TypeUnited States, Israel
-
University of MiamiNational Institute of Neurological Disorders and Stroke (NINDS); National Institutes...RecruitingAmyotrophic Lateral Sclerosis | Primary Lateral Sclerosis | Frontotemporal Dementia | Progressive Muscular Atrophy | Hereditary Spastic ParaplegiaUnited States, South Africa
-
Newron Pharmaceuticals SPACompletedParkinson's DiseaseAustria, Canada, France, Germany, South Africa
-
Eisai Inc.Eisai LimitedCompletedAttention ImpairmentUnited States, Netherlands, France, Spain, United Kingdom, Germany, Argentina, Canada, Australia, Chile
-
Eli Lilly and CompanyCompletedAttention Deficit Hyperactivity Disorder | Oppositional Defiant DisorderAustralia, Belgium, Denmark, Finland, Germany, Netherlands, Spain, United Kingdom
-
Johnson & Johnson Pharmaceutical Research & Development...CompletedAttention Deficit Hyperactivity DisorderUnited States
-
AbbVie (prior sponsor, Abbott)CompletedAttention-Deficit/Hyperactivity DisorderUnited States
-
Supernus Pharmaceuticals, Inc.CompletedAttention-Deficit/Hyperactivity Disorder (ADHD)United States, Puerto Rico
-
ShireCompletedAttention-deficit/Hyperactivity DisorderUnited States, Canada, Germany, Hungary, Sweden
-
Novartis PharmaceuticalsTerminatedAmnestic Mild Cognitive Impairment | Mild Alzheimer's DiseaseCanada, United Kingdom, South Africa
-
AbbVie (prior sponsor, Abbott)CompletedAttention Deficit Hyperactivity DisorderUnited States
-
CephalonCompletedADHD | Attention Deficit Hyperactivity DisorderUnited States
-
AbbottTerminatedAttention-Deficit/Hyperactivity DisorderUnited States
-
Minster Research LtdCompletedMigraine Without Aura | Migraine With AuraUnited Kingdom, Denmark, Hungary, South Africa
-
University of CincinnatiNational Institute on Drug Abuse (NIDA); University of Colorado, DenverCompletedADHD | Substance AbuseUnited States
-
ShireCompletedAttention-Deficit/Hyperactivity DisorderUnited States
-
ShireCompletedAttention-Deficit/Hyperactivity DisorderUnited States
-
Johnson & Johnson Pharmaceutical Research & Development...CompletedAttention Deficit Hyperactivity DisorderUnited States
-
AbbottCompletedADHD | Attention-Deficit/Hyperactivity DisorderUnited States
-
AbbottCompletedAttention-Deficit/Hyperactivity DisorderUnited States
-
Arbor Pharmaceuticals, Inc.CompletedAttention Deficit Hyperactivity DisorderUnited States
-
Supernus Pharmaceuticals, Inc.CompletedAttention Deficit Hyperactivity Disorder (ADHD)United States
-
SunovionCompleted
-
Medical University of South CarolinaNational Institute on Drug Abuse (NIDA); National Institutes of Health (NIH); University of MinnesotaRecruitingSmoking Prevention and ControlUnited States
-
SunovionCompletedAdult Attention Deficit Hyperactivity DisorderUnited States
-
ShireCompletedAttention-deficit/Hyperactivity DisorderUnited States
-
Eli Lilly and CompanyCompletedAttention Deficit Hyperactivity DisorderItaly, Spain, France, Belgium, Turkey, Ireland, Mexico, Norway, United Kingdom
-
National Institute of Allergy and Infectious Diseases...CompletedHIV Infections | Cryptococcal MeningitisKenya, Thailand, Uganda, United States, Peru, South Africa, Zimbabwe, India
-
Genzyme, a Sanofi CompanyCompletedGlycogen Storage Disease Type II | Pompe Disease Infantile-OnsetUnited States, France, South Africa
-
Purdue Pharma LPTerminatedAttention-Deficit/Hyperactivity DisorderUnited States
-
Otsuka Pharmaceutical Development & Commercialization...CompletedAttention Deficit Hyperactivity DisorderUnited States
-
ShireCompletedAttention Deficit Hyperactivity Disorder (ADHD)United States
-
Supernus Pharmaceuticals, Inc.CompletedImpulsive Aggression Comorbid With ADHDUnited States
-
Eli Lilly and CompanyCompletedAttention Deficit Hyperactivity Disorder | Comorbid Social Anxiety DisorderUnited States, Puerto Rico
-
Medical University of South CarolinaCompleted
-
ShireTerminatedAttention Deficit Hyperactivity Disorder (ADHD)United States
-
ShireCompletedAttention Deficit Hyperactivity Disorder (ADHD)United States
-
ShireCompletedAttention Deficit Hyperactivity Disorder (ADHD)United States
-
Supernus Pharmaceuticals, Inc.CompletedAttention Deficit Hyperactivity Disorder (ADHD)United States
-
ShireCompletedAttention Deficit Hyperactivity Disorder (ADHD)United States